Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2014-12-31
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Kidney Injury in Premature Infants
NCT00573079
Acute Kidney Injury in Neonates
NCT00572715
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115
Outcomes of Neonatal Acute Kidney Injury In Premature Infants
NCT02375854
Long-term Renal Prognosis of Neonatal Acute Kidney Injury
NCT06731205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premature Acute Kidney Injury in NICU
This group of babies born less than 1500 grams will have experienced acute kidney injury based on the modified KDIGO guidelines for acute kidney injury.
No interventions assigned to this group
Premature No Acute Kidney Injury in NICU
This group of babies born less than 1500 grams will have not experienced acute kidney injury in the NICU.
No interventions assigned to this group
Term No Acute Kidney Injury
This group of babies born at term will have not experienced any acute kidney injury.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* UVA NICU admission prior to 2 days of life
* Birth weight less than 1500 grams for premature groups
* Premature AKI Study group: Acute Kidney Injury as defined by KDIGO modified criteria during NICU stay at UVA
* Premature no AKI Control group: No AKI during NICU stay
* Term no AKI Control group: No AKI and born at term
* Parental or legal guardian consent obtained
Exclusion Criteria
2 Years
7 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Matthew Harer, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthew Harer, MD
Neonatal-Perinatal Medicine Fellow, MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Virginia
Charlottesville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17540
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.